Skip to main content

Table 3 Summary metrics derived from using one replicate of each sample per round

From: Summarizing performance for genome scale measurement of miRNA: reference samples and metrics

Measurement

 

Data Source

miRNA Detected

Log2 Signals

AUCc

Deviation

Process

Technology

by Round

 

Non-

TrueNeg

TruePos

Lower

Upper

Range

All

Within

Log2 Ratio

Proportion

  

Pure

Mixes

Reps

Selective

1-to-1a

Brain

Placenta

Limitb

Limit

Range

Median

IQR

Sum

A

NGS

3

3

1

671

43

93

89

7.1

20.0

12.9

0.856

1.000

0.094

0.386

0.394

4

4

1

696

51

98

91

8.0

20.2

12.2

0.921

0.996

0.081

0.492

0.399

5

5

1

692

36

96

95

9.5

20.2

10.8

0.793

0.971

-0.102

0.545

0.323

B

NGS

3

3

1

618

35

109

37

8.9

20.1

11.2

0.832

0.969

-0.055

0.405

0.559

4

4

1

527

35

97

33

8.0

19.0

11.0

0.910

0.972

-0.106

0.384

0.417

5

5

1

455

28

73

32

7.8

19.2

11.4

0.849

1.000

-0.031

0.354

0.456

C

NGS

3

3

1

326

11

26

39

6.6

16.3

9.7

0.905

0.983

0.030

0.323

0.348

4

4

1

158

12

15

4

8.4

11.8

3.5

0.704

1.000

0.001

0.617

0.382

5

5

1

247

13

18

15

12.0

12.5

0.5

0.795

NDd

-0.031

0.756

0.498

D

NGS

3

3

1

151

6

18

3

−

10.5

−

0.648

NDd

-0.235

0.969

0.644

4

4

1

205

13

20

3

7.6

10.5

3.0

0.903

0.950

-0.126

0.569

0.471

E

Digital Hybridization

3

3

1

702

63

6

19

13.2

13.4

0.2

0.898

NDd

-0.077

0.661

0.635

4

4

1

618

27

12

24

14.6

15.4

0.8

0.727

NDd

-0.340

0.670

0.376

5

5

1

599

38

17

37

7.5

15.3

7.9

0.774

1.000

-0.165

0.749

0.511

  1. aLiver-selective miRNA or miRNA with approximately equal signals in both brain and placenta
  2. bLower limits for NGS and digital hybridization were calculated with at 95% of values falling within ± 0.585 log2 difference from mean
  3. cROC curves were prepared using ordered log2 ratios and a single replicate
  4. dNot determined (ND) due to insufficient number of true negative or true positive values